INTRODUCTION
Since 1993, the Japanese shrimp industry has been hampered by the appearance of penaeid rod-shaped DNA virus (PRDV) which causes penaeid acute viremia (PAV) (Takahashi et al. 1998 ). In the beginning of the PAV epizootic, mass mortalities were observed only from farms where Penaeus japonicus seed stocks were imported from China , Takahashi et al. 1994 ). This event was followed by a rapid spread of the disease affecting the harvesting rates of farmed kuruma prawn in all western Japan. The etiological agent was described as a rod-shaped enveloped bacilliform virus, tentatively named RV-PJ (rod-shaped nuclear virus of P. japonicus) . Later it was renamed PRDV along with the disease name, PAV . The same disease, generally called white spot syndrome (WSS, Lightner 1996) , has been reported in shrimp farming regions of Asia (Chou et al. 1995 , Peng et al. 1995 , Wongteerasupaya et al. 1995 , Karunasagar et al. 1997 , Park et al. 1998 and in the Americas (Nunan et al. 1998 , Jory 1999 , causing significant economic losses.
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KEY WORDS: Penaeid acute viremia (PAV) · Penaeid rod-shaped DNA virus (PRDV) · White spot syndrome virus (WSSV) · Immune response · Penaeus japonicus Resale or republication not permitted without written consent of the publisher range among penaeid shrimp (Lightner 1996) and other crustaceans (Lo et al. 1996 , Maeda et al. 1998a . So far, PAV has caused mass mortalities in cultured kuruma prawn and greasyback shrimp Metapenaeus ensis in Japan (Momoyama et al. 1997) . It was experimentally demonstrated that 6 species of crustaceans, the major species for seed production programs in Japan, are all susceptible to PRDV, although some (Penaeus semisulcatus and Portunus trituberculatus) have a lower susceptibility than P. japonicus (Momoyama et al. 1999 ). However, it was revealed that larval stages and younger postlarvae (PL) (younger than PL 10) of kuruma prawn were not susceptible to the virus .
The first microscopic diagnostic method was introduced based on the pathognomonic changes in affected shrimp, i.e. abundant presence of the viral particles in the hemolymph (viremia) and hypertrophied nuclei of the infected cells (Momoyama et al. 1995) . In 1996, PRDV-specific primers for polymerase chain reaction (PCR) detection were developed , Takahashi et al. 1996 . PCR, mainly with the primers developed by Kimura et al. (1996) , is widely used as the routine diagnostic means in Japan. In research work, an in situ hybridization technique has also been used to detect PRDV (Momoyama et al. 1999) .
Currently, the epizootiological landscape of PAV in Japan is quite different from that of the early stages. Although it has become an enzootic sanitary problem on Japanese coasts, due to countermeasures that have been practiced in shrimp farms and hatcheries the prevalence of the disease is not so high as in the first few years. Among them, the production of SPF (specific pathogen free) juveniles in hatcheries by means of selection of PRDV-negative wild broodstock (Mushiake et al. 1998 , 1999 ) and release of PRDV-negative juveniles to restock coastal waters (Yamano et al. 1998 ) have been effective for this amelioration. Effects of various chemical treatments on PRDV were tested (Maeda et al. 1998b , Nakano et al. 1998 ) and disinfection of eggs with iodine has been practiced , though strict efficacy has not yet been proven in hatcheries.
A phenomenon of tolerance has been observed in Penaeus monodon in Thailand in the cases of WSSV and YHV (yellow head virus) ). According to Flegel (1997) , the shrimp appeared to have rapidly developed a tolerance against the new virus (systemic ectodermal and mesodermal baculovirus, SEMBV: homologous to WSSV and PRDV) within a period of 1.5 yr since it first caused heavy losses. Flegel (1997) hypothesized that this specific viral tolerance was developed within the lifetime of a single batch of shrimp, but the exact mechanism is unknown. Concerning this phenomenon, Flegel & Pasharawipas (1998) hypothesized that tolerance to viral infections in crustaceans is the manifestation of an active system for accomodation that is based on membrane binding involving specific memory, leading to supression of viral triggered apoptosis and to persistent innocuous infections. However, data which indicate the presence of an acquired tolerance against PRDV (or WSSV) in penaeid shrimp have been scarce. A similar phenomenon was observed in a shrimp farm in Hiroshima, Japan, revealing a resistance in surviving shrimp against experimental PRDV challenge. Moreover, by artificial infection, the present authors could produce 'immune shrimp' whose resistance was confirmed by a viral re-challenge.
MATERIALS AND METHODS
This study began by monitoring the prevalence of infection in kuruma prawns following a PAV outbreak (Expt 1). The resistance of surviving shrimp (NS: natural survivors) was then tested by experimental challenge with PRDV (Expt 2). In order to artificially produce resistant individuals, kuruma shrimp were injected intramuscularly (IM) with PRDV, and survivors (ES: experimental survivors) were challenged again after 32 d of rearing in a tank or in individual chamber units (Expt 3). Serum samples obtained from NS shrimp and from surviving shrimp of Expt 2 (NES: surviving natural epizootic and subsequent experimental challenge) were tested for their neutralizing activity against PRDV (Expts 4 to 6).
For the challenge test, the following virus source was used in Expts 2 to 6, all of which were carried out in the Kamiura Station of Japan Sea-Farming Association (JASFA). Prior to and following the challenge, shrimp were reared at a water temperature ranging from 19 to 21°C and fed a commercial crumbled feed.
Virus source. A homogenate was made from naturally PRDV-infected juveniles of Penaeus japonicus, diluted 4 times in sterile phosphate-buffered saline (PBS) and then centrifuged at 1600 × g for 10 min at 4°C. The supernatant was filtered through a 0.45 µm cellulose acetate membrane, collected and stored at -80°C until the infection trials were performed.
PCR analysis for PRDV. Muscle was homogenized and digested in a mixed solution containing proteinase K (1 mg m -1 ; Merck) and SDS (1% w/v). After incubation at 37°C for 15 min, the DNA extraction was done following a protocol designed in our laboratory (Nonaka et al. 1998) . Briefly, the DNA was extracted twice with phenol-saturated TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and once with chloroform/ isoamylalcohol (24:1). The solution was then treated with 5 M ammonium acetate and absolute ethanol, centrifuged (12 000 × g, 15 min) and submitted to RNase A (20 µg ml -1 ; Nacalai tesque) digestion. Thereafter, the DNA was recovered by treatment with 20% PEG 6000 solution, washed with 70% (v/v) ethanol by centrifugation (12 000 × g, 2 min) and dried. The dried pellets were then resuspended in TE buffer. The detection primers used were P1-P2 (for 1st-step PCR) and P3-P4 (for 2nd-step) previously described by for PRDV diagnosis. The detection was performed by 1-step amplification for 30 (without notice) or 40 cycles in a temperature control system (Astec PC-800, Japan). Negative samples were submitted to a 2nd amplification (nested PCR).
For electrophoresis of the PCR products, 1.5% agarose gels in 0.5 × TAE (40 mM Tris-acetate pH 8.0, 0.1 mM EDTA) were used. After electrophoresis, the minigels were stained with ethidium bromide and visualized by ultraviolet transillumination. Expt 1. Field monitoring for prevalence of infected shrimp. A survey of the occurrence of PAV and prevalence of PRDV was conducted from July to November 1997 (summer and autumn seasons) in a private shrimp farm located in Hiroshima Prefecture in western Japan. On each sampling date, 6 or 10 live individuals were sampled and submitted to PCR amplification for detection of PRDV following the extraction method described above.
Expt 2. PRDV challenge of NS. In November 1997 (about 4 mo after a natural outbreak), NS were challenged with the PRDV preparation with a control counterpart derived from naive shrimp obtained from a farm in Kagoshima Prefecture without history of PAV occurrence in that year. Prior to the challenge, shrimp from both groups were checked for the presence of PRDV by PCR (1-step, 40 cycles). For challenge of the NS and naive shrimp, a dose of 100 µl of 10 -2 diluted PRDV preparation was injected IM, while control shrimp of the 2 types were injected with sterile PBS. For each group 20 individuals with an average body weight of 20 g were used (total 80). After the challenge, the shrimp were held in 500 l tanks supplied with flowing seawater and aeration. Mortalities were recorded through a period of 16 d. Dead shrimp were submitted to PCR tests for detection of PRDV. NES shrimp were retained for further study.
Expt 3. PRDV challenge of ES. ES were used in a challenge test with PRDV. To produce ES, shrimp ranging 1.5 to 2 g in body weight (n = 318), derived from PRDV-negative broodstock and raised in Kamiura Station without PAV experience, were challenged by IM injection with 10 -8 dilution of the viral preparation at a dose of 10 µl ind. . Afterwards, 213 of the challenged shrimp were collectively held in a 500 l plastic tank (collectively reared, 'Coll' group) while the remainder were held in individual chamber units (i.e. 105 chambers filled with 600 ml seawater each; individually reared, 'Ind' group). Another group from the same batch was injected with sterile PBS (n = 150) in order to provide a control group for the subsequent challenges. The PRDV-challenged shrimp were observed until peak mortality had passed (i.e., 32 d after injection challenge). Mortalities were confirmed as specific for PRDV by PCR, but PCR tests were not applied to the survivors before re-challenge.
In the re-challenge test, a dose of 10 µl of a 10 -4 dilution of the viral preparation was injected IM into each of 23 survivors from the 'Coll' and 'Ind' groups. A group of 25 of the control shrimp, previously injected with PBS, was also challenged with the same viral dilution. The shrimp of each group were held collectively in separate 30 l plastic tanks supplied with flowing water and aeration. For mortality, the shrimp were observed for 16 ('Coll' group) or 17 ('Ind' group) d, and dead shrimp were tested by PCR for PRDV.
Expt 4. Challenge using PRDV mixed with NS serum. Serum from natural PAV-survivors (NS serum) was collected about 4 mo after the farm disease outbreak. From each shrimp 0.5 ml of hemolymph was drawn without any anticoagulant but by diluting 5 times with PBS in the syringe followed by centrifugation (1600 × g, 5 min) to remove hemocytes. The NS serum obtained (0.1 ml) was mixed with 0.9 ml of the PRDV preparation (diluted 10 -2 ) and kept for 3 h at 20°C. The serum-virus mixture was then injected IM at a dose of 100 µl per 20 g naive shrimp. Naive positive controls were injected with PRDV mixed with normal serum or with PBS and naive negative controls with PBS alone. Afterwards, the shrimp were held in 500 l tanks with a flow through water system and monitored for survival for 24 d. This experiment was run together with Expt 5, so that the same controls served for both.
Expt 5. Challenge using PRDV mixed with NES serum. Serum from survivors of Expt 2 (NES) was collected and treated in the same manner as in Expt 4 and injected similarly into 20 g naive shrimp using the same positive and negative controls as in Expt 4. Afterwards, the shrimp were held in 500 l tanks with a flow through water system and monitored for survival for 24 d.
Expt 6. PRDV neutralization test with NES serum. A neutralizing experiment with NES serum was carried out using younger naive shrimp (1.5 g). In this experiment, in order to avoid effects of NES serum in injected experimental specimens, the virus-serum mixture was ultracentrifugated (30 000 × g, 45 min at 4°C) after being kept at 20°C for 3 h and PRDV was resuspended in the original volume of PBS prior to IM injection (10 µl shrimp -1
). There were 2 positive control groups, 1 injected IM with uncentrifuged PRDV prepa-ration and 1 with ultracentrifuged and reconstituted PRDV preparation. The negative control group was injected with PBS.
Statistical methods. The mortalities of the tested and control groups were statistically compared using chisquare test (χ 2 ) at a significance level of 5% and the relative percent survival [RPS %= (1-'vaccinated' group mortality/control group mortality) × 100] was also calculated (Amend 1981) .
RESULTS

Expt 1. Prevalence of PRDV-infected shrimp in the
sampled farm (Table 1) The shrimp sampled on July 3 revealed no presence of PRDV DNA and no significant mortality was recorded in the farm. In late July (middle of summer), a PAV outbreak occurred in the farm resulting in high mortality (estimated 60%) with PCR-positive results in all sampled individuals. However, after the peak of the epizootic, few of the surviving shrimp died from PAV in the late summer and autumn, despite the persistence of PRDV in the survivors as indicated by PCR tests. (Fig. 1) Prior to challenge, 1-step PCR positive rates of the NS and PAV-inexperienced control shrimp were 43 and 0%, respectively. A significant difference in survival rate after the challenge test was observed between the NS and control shrimp (95 and 20%, respectively) with an RPS of 94% for the NS group. Positive PCR reactions were detected from all dead shrimp.
Expt 2. Challenge of NS shrimp
Expt 3. PRDV challenge of ES (Fig. 2)
Cumulative mortalities during 32 d following the preparatory laboratory challenge were 59, 10, and 3%, in 'Coll' and 'Ind' groups and the PBS injected control group, respectively. The mortalities were significantly different (p < 0.05) between the 'Coll' and 'Ind' groups. When the PAV survivors (ES-'Coll' and ES-'Ind') and the PBS-injected control shrimp were subsequently challenged with PRDV, both ES groups gave significantly different survival rates (p < 0.05) from the control group (see Fig. 2 64% for the ES-'Coll' and ES-'Ind' groups, respectively. Most of the dead shrimp were confirmed to be PRDV positive by PCR. However, PRDV DNA could not be detected from decaying carcasses. The PCR detection rates in survivors after the re-challenge were 27% (5/18) and 0% (0/18) in the ES-'Coll' and ES-'Ind' groups, respectively.
Expt 4. Challenge using PRDV mixed with NS serum (Fig. 3) The group challenged with the mixture of virus and NS serum had a survival rate of 15% when compared to the negative control group of 100% and the 2 positive control groups, one injected with non-treated virus (30%) and the other with a mixture of virus and normal serum (35%). Thus, the NS serum showed no protective effect.
Expt 5. Challenge using PRDV mixed with NES serum (Fig. 3) A significantly higher survival rate of 85% was revealed in the group challenged with a mixture of PRDV and NES serum when compared to the 2 foregoing positive control groups. An interesting observation was a high detection rate for PRDV by 1-step PCR (60%) among the survivors.
Expt 6. PRDV neutralization test with NES serum (Table 2)
A similar high survival rate (77%) was attained in the group of younger shrimp injected with virus solution prepared by mixing with NES serum followed by ultracentrifugation. The RPS was 71% ( Table 2) . As with Expt 5, there was a high detection rate for PRDV among the survivors (45%).
DISCUSSION
The protective system in invertebrates has often been called primitive in comparison with that of vertebrates. However, this group of shrimp must have their own effective protective 'immune system'. This efficient system does not rely on an adaptive immune response based on immunoglobulins which characterize a 'true immune response'. Concerning immune defense, crustaceans are able to recognize self from non-self (Sloan et al. 1975 ) by means of efficient and rapid defense processes involving cellular responses (e.g. clotting, phagocytosis and encapsulation) (Söder-häll & Cerenius 1992) and humoral responses (agglutinins, lectins, killing factors, neutralizing factors, etc.) (Smith & Chisholm 1992) . These responses have now become important due to the new emerging viral diseases facing the shrimp culture industry, e.g. YHD (Flegel 1997) , Taura syndrome (TS; Lightner & Redman 1998) , and WSS/PAV. Currently, the epizootiology of YHD and WSS shows a decrease in mortalities owing to a kind of tolerance that may be triggered in the shrimp (Flegel & Pasharawipas 1998) . It has also been reported for TSV that survivors of naturally occurring epizootics were resistant to subsequent infection if challenged by TSV (Lightner & Redman 1998) . However, few data demonstrating the presence of tolerance or resistance have been presented. Our investigation represents the first attempt to determine whether this kind of immune response could be triggered in shrimp by infection with PRDV in natural and experimental situations. In our first experiment, it was observed that PAV recurrence scarcely occurred in the studied shrimp farm, despite the high prevalence of PRDV infection in surviving shrimp (NS) detected by PCR tests. Upon experimental challenge with PRDV, these NS shrimp showed high survival (95%) when compared to the control shrimp (20%). Since the control shrimp in this experiment comprised Penaeus japonicus obtained from a different location than the NS shrimp (because naive shrimp could not be obtained from the same or neighbouring farms), it might be argued that the differences in survival in the experiment were due to differences in natural resistance to PRDV as a result of selection during the PAV outbreak. We attempted to test this argument in Expt 3, where the ES shrimp and control shrimp were derived from the same batch of test animals in order to avoid genetic variation. We also reared the ES shrimp collectively and individually to test effects of crowding stress. Although the results of Expt 3 confirmed that PAV survivors were protected upon re-challenge with PRDV, there were significant differences (p < 0.05) in mortalities for shrimp reared collectively (59%) and individually (10%) during the preparatory challenge phase for the experiment. Thus, the possibility for some selection of innately resistant individuals remains open, since there was higher cumulative mortality in the 'Coll' group than in the 'Ind' group. In spite of this, the fact that RPS for the collectively and individually reared ES shrimp were both very high (77 and 64%) and not greatly different indicates that the PRDV protection resulted largely from exposure to the virus and not to innate resistance. Thus, the protection appeared to be acquired after exposure to the virus and might be called a 'quasiimmune response'.
It is not clear why there was a significant difference after PRDV challenge in the mortality of 'Coll' shrimp and 'Ind' shrimp. It could have been brought about by differences in stress or by cannibalism in one group but not the other. However, detailed studies should be carried out to elucidate the effect of rearing conditions on the outcome of infections.
Although we did not examine other factors, including cellular ones, our experiments with serum-virus mixtures (i.e., the neutralization tests) suggest that there may be a PRDV neutralizing factor (or non-specific binding factor) in the hemolymph of NES for up to 17 d after challenge with PRDV. However, such apparent neutralizing activity was not detected from ES 4 mo after a PAV outbreak, even though they gave high survival (95%) upon PRDV challenge. This means that the 'neutralizing factor' is not indispensable for the acquired protection shown in the present study. Possibly, this 'neutralizing factor' does not continue to exist long after exposure to virus but may be enhanced by secondary exposure (laboratory challenge). As mentioned in a study on the convalescent stage of experimental TS in Penaeus vannamei (Hasson et al. 1999 ), a cellmediated defense mechanism might also be involved in the present 'quasi-immune response'.
As mentioned above, Flegel & Pasharawipas (1998) presented an interesting hypothesis on acquired tolerance of shrimp to viral pathogens. So far we could confirm the basic phenomenon of acquired resistance or a 'quasi-immune response' in Penaeus japonicus to PRDV, but we have no further materials to make available arguments to support or criticize their hypothesis. The positive PCR results were sometimes observed in resistant survivors at the end of re-challenge tests, but we did not examine whether the virus positively replicated in them or not. In our study, important tasks remain to elucidate the duration and specificity of the 'quasi-immune response' and the nature of the factors, humoral and cellular, involved in the phenomenon.
